XML 77 R52.htm IDEA: XBRL DOCUMENT v3.22.1
Notes Receivable - Additional Information (Detail)
$ / shares in Units, shares in Millions
9 Months Ended 12 Months Ended
Sep. 14, 2021
USD ($)
May 14, 2021
USD ($)
May 11, 2021
USD ($)
Dec. 03, 2020
USD ($)
Apr. 17, 2020
USD ($)
shares
Apr. 17, 2020
GBP (£)
Jan. 03, 2020
USD ($)
$ / shares
Sep. 30, 2021
Dec. 31, 2021
USD ($)
$ / shares
Dec. 31, 2020
USD ($)
$ / shares
Dec. 31, 2019
USD ($)
Dec. 31, 2019
GBP (£)
Dec. 31, 2021
€ / shares
Jun. 07, 2021
€ / shares
Mar. 08, 2021
USD ($)
Dec. 31, 2020
€ / shares
Dec. 03, 2020
GBP (£)
Apr. 17, 2020
GBP (£)
shares
Nov. 06, 2019
USD ($)
Nov. 06, 2019
GBP (£)
Sep. 27, 2019
USD ($)
Sep. 27, 2019
GBP (£)
Notes Receivable [Line Items]                                            
Payments to acquire notes receivable                 $ 1,916,000                        
Proceeds from issuance of equity   $ 3,000,000.0                                        
Issuance of common stock shares par value | (per share)                 $ 0.12 $ 0.12     € 0.10 € 0.10   € 0.10            
Amended and Restated Loan Agreement [Member]                                            
Notes Receivable [Line Items]                                            
Loan agreement $ 6,000,000.0                                          
Term Loan Receivable [Member]                                            
Notes Receivable [Line Items]                                            
Loans and lease receivable, Outstanding                 $ 2,500,000                          
Loans Receivable [Member]                                            
Notes Receivable [Line Items]                                            
Receivables, Maturity description               On May 14, 2021, the Company amended the Term Loans under which the Maturity Date will be the first business day following the first closing of a subscription for additional units if the proceeds from such subscription amount to at least $3.0 million.                            
Compass Shareholder [Member]                                            
Notes Receivable [Line Items]                                            
Receivable, Face amount       $ 900,000                         £ 700,000          
Payments to acquire notes receivable                     $ 7,800,000 £ 6,200,000                    
Receivables, Interest rate       0.00%                                    
Receivables, Due date       Apr. 01, 2022                                    
Receivables, Termination                 2021-04                          
Securities Issued Upon Qualified Equity Financing                                     $ 33,200,000 £ 25,000,000    
Securities Issued Upon Non-Qualified Equity Financing                                     33,200,000 25,000,000    
Discount To Price Per Share Paid For Preferred Shares         15.00% 15.00%                                
Conversion Price         $ 3,181                         £ 2,397        
Notes Receivable, Fair Value Disclosure         700,000                                  
Compass Shareholder [Member] | Notes Receivable Related Parties Current [Member]                                            
Notes Receivable [Line Items]                                            
Due from related party, Current                   $ 900,000                        
Compass Shareholder [Member] | Series B Preferred Stock [Member]                                            
Notes Receivable [Line Items]                                            
Payments to acquire notes receivable         $ 7,600,000 £ 6,200,000                                
Convertible promissory notes, interest rate         85.00%                         85.00%        
Preferred stock | shares         49.8                         49.8        
Notes Receivable, Fair Value Disclosure         $ 9,000,000.0                                  
Acquired notes receivable fair value disclosure         $ 1,654                         £ 1,350        
IntelGenx Corp [Member]                                            
Notes Receivable [Line Items]                                            
Loans receivable, Fixed interest rate                 8.00%                          
IntelGenx Corp [Member] | Additional Term Loan And March Term Loan [Member]                                            
Notes Receivable [Line Items]                                            
Payments to acquire notes receivable     $ 500,000                                      
IntelGenx Corp [Member] | March Term Loan Receivable [Member]                                            
Notes Receivable [Line Items]                                            
Receivable, Face amount                             $ 2,000,000.0              
IntelGenx Corp [Member] | Additional Term Loan Receivable [Member]                                            
Notes Receivable [Line Items]                                            
Receivable, Face amount                             $ 500,000              
IntelGenx Corp [Member] | Additional Term Loan Receivable [Member] | Amended and Restated Loan Agreement [Member]                                            
Notes Receivable [Line Items]                                            
Receivable, Face amount 6,000,000.0                                          
IntelGenx Corp [Member] | Additional Term Loan Receivable [Member] | First Tranche [Member] | Amended and Restated Loan Agreement [Member]                                            
Notes Receivable [Line Items]                                            
Receivable, Face amount 3,000,000.0                                          
IntelGenx Corp [Member] | Additional Term Loan Receivable [Member] | Second Tranche [Member] | Amended and Restated Loan Agreement [Member]                                            
Notes Receivable [Line Items]                                            
Receivable, Face amount 3,000,000.0                                          
IntelGenx Corp [Member] | Term Loan Receivable [Member]                                            
Notes Receivable [Line Items]                                            
Receivable, Face amount $ 8,500,000                                          
Receivables, Maturity terms               120 days                            
IntelGenx Corp [Member] | Term Loan Receivable [Member] | Amended and Restated Loan Agreement [Member]                                            
Notes Receivable [Line Items]                                            
Term loan maturity date Jan. 05, 2024                                          
DemeRx IB, Inc. [Member] | Minimum [Member]                                            
Notes Receivable [Line Items]                                            
Debt Instrument, interest rate increase             6.00%                              
DemeRx IB, Inc. [Member] | Maximum [Member]                                            
Notes Receivable [Line Items]                                            
Debt Instrument, interest rate increase             11.00%                              
Promissory Note Agreement [Member]                                            
Notes Receivable [Line Items]                                            
Convertible promissory notes issued | £                                           £ 3,000,000.0
Promissory Note Agreement [Member] | Compass Shareholder [Member]                                            
Notes Receivable [Line Items]                                            
Convertible promissory notes issued                                     $ 4,200,000 £ 3,200,000 $ 4,000,000.0  
Convertible promissory notes, interest rate                 3.00%                          
Promissory Note Agreement [Member] | DemeRx [Member]                                            
Notes Receivable [Line Items]                                            
Payments to acquire notes receivable             $ 1,000,000.0                              
Receivables, Maturity terms             360 days                              
Debt Instrument, interest rate of unpaid principal balance             6.00%                              
Debt Instrument, face amount inclusive other payments             $ 1,000,000.0                              
Debt Instrument, Description             the aggregate principal amount of $1.0 million together with all accrued and unpaid interest and any other amounts payable are due to be paid on the date that is the earlier of (i) 5 years from the initial closing and (ii) the closing of an initial public offering or a deemed liquidation event of DemeRx IB (the “DemeRx Maturity Date”)                              
DemeRx Note [Member] | DemeRx IB, Inc. [Member]                                            
Notes Receivable [Line Items]                                            
Issuance of common stock shares par value | $ / shares             $ 0.0001                              
DemeRx Note [Member] | DemeRx [Member]                                            
Notes Receivable [Line Items]                                            
Loans and lease receivable, Outstanding                 $ 1,100,000 $ 1,100,000